A citation-based method for searching scientific literature

Noam A VanderWalde, Michelle T Chi, Arti Hurria, Matthew D Galsky, Matthew E Nielsen. World J Urol 2016
Times Cited: 13







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.
Phillip J Gray, Stacey A Fedewa, William U Shipley, Jason A Efstathiou, Chun Chieh Lin, Anthony L Zietman, Katherine S Virgo. Eur Urol 2013
155
23

A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy.
Matthew D Galsky, Noah M Hahn, Jonathan Rosenberg, Guru Sonpavde, Thomas Hutson, William K Oh, Robert Dreicer, Nicholas Vogelzang, Cora Sternberg, Dean F Bajorin,[...]. Lancet Oncol 2011
165
23

Is robotic-assisted radical cystectomy (RARC) with intracorporeal diversion becoming the new gold standard of care?
Hitendra R H Patel, Pedro Bargão Santos, Manuel Castanheira de Oliveira, Stig Müller. World J Urol 2016
14
15


EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.
J Alfred Witjes, Eva Compérat, Nigel C Cowan, Maria De Santis, Georgios Gakis, Thierry Lebret, Maria J Ribal, Antoine G Van der Heijden, Amir Sherif. Eur Urol 2014
697
15


International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature.
Stuart M Lichtman, Hans Wildiers, Etienne Chatelut, Christopher Steer, Daniel Budman, Vicki A Morrison, Brigitte Tranchand, Iuliana Shapira, Matti Aapro. J Clin Oncol 2007
147
15

Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.
Hans von der Maase, Lisa Sengelov, James T Roberts, Sergio Ricci, Luigi Dogliotti, T Oliver, Malcolm J Moore, Annamaria Zimmermann, Michael Arning. J Clin Oncol 2005
15

Predictors of early death risk in older patients treated with first-line chemotherapy for cancer.
Pierre Soubeyran, Marianne Fonck, Christèle Blanc-Bisson, Jean-Frédéric Blanc, Joël Ceccaldi, Cécile Mertens, Yves Imbert, Laurent Cany, Luc Vogt, Jerôme Dauba,[...]. J Clin Oncol 2012
269
15

Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987.
Joaquim Bellmunt, Hans von der Maase, Graham M Mead, Iwona Skoneczna, Maria De Santis, Gedske Daugaard, Andreas Boehle, Christine Chevreau, Luis Paz-Ares, Leslie R Laufman,[...]. J Clin Oncol 2012
278
15

Quality Improvement in Cystectomy Care with Enhanced Recovery (QUICCER) study.
Janet E Baack Kukreja, Maureen Kiernan, Bethany Schempp, Aisha Siebert, Adriana Hontar, Benjamin Nelson, James Dolan, Katia Noyes, Ann Dozier, Ahmed Ghazi,[...]. BJU Int 2017
27
15

Preliminary Comparative Effectiveness of Robotic Versus Open Radical Cystectomy in Elderly Patients.
Brian R Winters, Prashoban J Bremjit, John L Gore, Daniel W Lin, William J Ellis, Bruce L Dalkin, Michael P Porter, Jonathan D Harper, Jonathan L Wright. J Endourol 2016
22
15


A randomized trial of robot-assisted laparoscopic radical cystectomy.
Bernard H Bochner, Daniel D Sjoberg, Vincent P Laudone. N Engl J Med 2014
69
15

Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy.
Meera R Chappidi, Max Kates, Hiten D Patel, Jeffrey J Tosoian, Deborah R Kaye, Nikolai A Sopko, Danny Lascano, Jen-Jane Liu, James McKiernan, Trinity J Bivalacqua. Urol Oncol 2016
63
15

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.
Sebastien Antoni, Jacques Ferlay, Isabelle Soerjomataram, Ariana Znaor, Ahmedin Jemal, Freddie Bray. Eur Urol 2017
15

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
Joaquim Bellmunt, Ronald de Wit, David J Vaughn, Yves Fradet, Jae-Lyun Lee, Lawrence Fong, Nicholas J Vogelzang, Miguel A Climent, Daniel P Petrylak, Toni K Choueiri,[...]. N Engl J Med 2017
15



Open radical cystectomy: still the gold standard for muscle invasive bladder cancer.
Bernhard Kiss, Fiona C Burkhard, George N Thalmann. World J Urol 2016
11
9

Immune checkpoint inhibitors: a new frontier in bladder cancer.
Max Kates, Nikolai A Sopko, Hotaka Matsui, Charles G Drake, Noah M Hahn, Trinity J Bivalacqua. World J Urol 2016
12
8


Orthotopic urinary diversion in the elderly.
Cory M Hugen, Siamak Daneshmand. World J Urol 2016
6
16


Enhanced recovery from surgery in the UK: an audit of the enhanced recovery partnership programme 2009-2012.
J C Simpson, S R Moonesinghe, M P W Grocott, M Kuper, A McMeeking, C M Oliver, M J Galsworthy, M G Mythen. Br J Anaesth 2015
84
7

Postoperative Pain Management after Radical Cystectomy: Comparing Traditional versus Enhanced Recovery Protocol Pathway.
Weichen Xu, Siamak Daneshmand, Soroush T Bazargani, Jie Cai, Gus Miranda, Anne K Schuckman, Hooman Djaladat. J Urol 2015
53
7




Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.
H von der Maase, S W Hansen, J T Roberts, L Dogliotti, T Oliver, M J Moore, I Bodrogi, P Albers, A Knuth, C M Lippert,[...]. J Clin Oncol 2000
7

The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy.
A Bamias, E Efstathiou, L A Moulopoulos, D Gika, G Hamilos, M P Zorzou, C Kakoyiannis, E Kastritis, G Bozas, C Papadimitriou,[...]. Ann Oncol 2005
54
7

Bladder cancer.
Peter E Clark, Neeraj Agarwal, Matthew C Biagioli, Mario A Eisenberger, Richard E Greenberg, Harry W Herr, Brant A Inman, Deborah A Kuban, Timothy M Kuzel, Subodh M Lele,[...]. J Natl Compr Canc Netw 2013
261
7

Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy.
Matthew D Galsky, Erin Moshier, Susan Krege, Chia-Chi Lin, Noah Hahn, Thorsten Ecke, Guru Sonpavde, James Godbold, William K Oh, Aristotle Bamias. Cancer 2013
63
7

Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology.
Jean-Pierre Droz, Matti Aapro, Lodovico Balducci, Helen Boyle, Thomas Van den Broeck, Paul Cathcart, Louise Dickinson, Eleni Efstathiou, Mark Emberton, John M Fitzpatrick,[...]. Lancet Oncol 2014
137
7

Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial.
Joseph T Santoso, Joseph A Lucci, Robert L Coleman, Ilona Schafer, Edward V Hannigan. Cancer Chemother Pharmacol 2003
129
7

Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment.
Thomas Aparicio, Atika Navazesh, Isabelle Boutron, Nadia Bouarioua, Denis Chosidow, Mathieu Mion, Laurence Choudat, Iradj Sobhani, France Mentré, Jean Claude Soulé. Crit Rev Oncol Hematol 2009
66
7

Current approaches to the management of bladder cancer in older patients.
Kristian D Stensland, Matthew D Galsky. Am Soc Clin Oncol Educ Book 2014
4
25

Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.
Arti Hurria, Kayo Togawa, Supriya G Mohile, Cynthia Owusu, Heidi D Klepin, Cary P Gross, Stuart M Lichtman, Ajeet Gajra, Smita Bhatia, Vani Katheria,[...]. J Clin Oncol 2011
947
7

First-line treatment and prognostic factors of metastatic bladder cancer for platinum-eligible patients.
Wassim Abida, Dean F Bajorin, Jonathan E Rosenberg. Hematol Oncol Clin North Am 2015
17
7

Concordance among gene-expression-based predictors for breast cancer.
Cheng Fan, Daniel S Oh, Lodewyk Wessels, Britta Weigelt, Dimitry S A Nuyten, Andrew B Nobel, Laura J van't Veer, Charles M Perou. N Engl J Med 2006
935
7

Optimizing the G8 Screening Tool for Older Patients With Cancer: Diagnostic Performance and Validation of a Six-Item Version.
Claudia Martinez-Tapia, Florence Canoui-Poitrine, Sylvie Bastuji-Garin, Pierre Soubeyran, Simone Mathoulin-Pelissier, Christophe Tournigand, Elena Paillaud, Marie Laurent, Etienne Audureau. Oncologist 2016
42
7

Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.
Pierre Soubeyran, Carine Bellera, Jean Goyard, Damien Heitz, Hervé Curé, Hubert Rousselot, Gilles Albrand, Véronique Servent, Olivier Saint Jean, Isabelle van Praagh,[...]. PLoS One 2014
236
7

Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer.
Matthew D Galsky, Susan Krege, Chia-Chi Lin, Noah Hahn, Thorsten H Ecke, Erin Moshier, Guru Sonpavde, James Godbold, William K Oh, Aristotle Bamias. Urol Oncol 2014
15
7


Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy.
D F Bajorin, P M Dodd, M Mazumdar, M Fazzari, J A McCaffrey, H I Scher, H Herr, G Higgins, M G Boyle. J Clin Oncol 1999
495
7

Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients - a large population-based study from 1990 to 2008.
Colette B M van den Broek, Esther Bastiaannet, Jan Willem T Dekker, Johanneke E A Portielje, Anton J M de Craen, Marloes A G Elferink, Cornelis J H van de Velde, Gerrit-Jan Liefers, Ellen Kapiteijn. Acta Oncol 2013
18
7

Is prostate cancer changing?: evolving patterns of metastatic castration-resistant prostate cancer.
Stephanie M Doctor, Che-Kai Tsao, James H Godbold, Matthew D Galsky, William K Oh. Cancer 2014
20
7

Relationship between 6- and 9-month progression-free survival and overall survival in patients with metastatic urothelial cancer treated with first-line cisplatin-based chemotherapy.
Matthew D Galsky, Susan Krege, Chia-Chi Lin, Noah Hahn, Thorsten Ecke, Erin Moshier, Guru Sonpavde, James Godbold, William K Oh, Aristotle Bamias. Cancer 2013
7
14

Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.
Maria De Santis, Joaquim Bellmunt, Graham Mead, J Martijn Kerst, Michael Leahy, Pablo Maroto, Iwona Skoneczna, Sandrine Marreaud, Ronald de Wit, Richard Sylvester. J Clin Oncol 2009
108
7

Influence of baseline renal function and dose reduction of nephrotoxic chemotherapeutic agents on the outcome of metastatic urothelial carcinoma: a retrospective study.
Shintaro Maru, Takashige Abe, Nobuo Shinohara, Ataru Sazawa, Satoru Maruyama, Toru Harabayashi, Shin Suzuki, Katsuya Nonomura. Int J Urol 2012
16
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.